Area of research
Hematology · Molecular Biology
Research interest
Research interests include Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Histone Deacetylase Inhibitors Research, and Epigenetics and DNA Methylation.
Treatment of Pleural Mesothelioma: ASCO Guideline Update
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations
Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
Germline variants drive myelodysplastic syndrome in young adults
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations
Transcription factor mutations as a cause of familial myeloid neoplasms
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
Germline Lysine-Specific Demethylase 1 ( <i>LSD1/KDM1A</i> ) Mutations Confer Susceptibility to Multiple Myeloma
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
Treatment of Acute Promyelocytic Leukemia in Adults
Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations
Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma.
Development of a Data Portal for Aggregation and Analysis of Genomics Data in Familial Platelet Disorder with Predisposition to Myeloid Malignancy - the RUNX1.DB
Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes
Recognition of familial myeloid neoplasia in adults
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia
Familial myelodysplastic syndrome/acute myeloid leukemia
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy